Products Antibodies Monoclonal Antibodies Rabbit anti-Human CD101/IGSF2 Monoclonal Antibody for IF/ICC, FC - Q93033

No Image

Monoclonal Antibodies

Rabbit anti-Human CD101/IGSF2 Monoclonal Antibody for IF/ICC, FC - Q93033

Item Number : CM0011952

Price varies based on specs and customizations


Application
IF/ICC, FC
Cross Reactivity
Human
Protein Weight
115kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name Rabbit anti-Human CD101/IGSF2 mAb
Remarks/Alias V7; IGSF2; EWI-101
Species Human
GeneID (Human) 9398
GeneID 9398
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 21-410 of human CD101/IGSF2 (NP_004249.2)
Source Rabbit
Category Monoclonal Antibodies
Application IF/ICC, FC
Cross Reactivity Human
SWISS Q93033
Protein Weight 115kDa
Shipping Ice bag

Biological Background: CD101/IGSF2 Function and Localization

  • CD101, also known as immunoglobulin superfamily member 2 (IGSF2), cell surface glycoprotein V7, and EWI-101, is a transmembrane glycoprotein belonging to the immunoglobulin superfamily.
  • It functions as an inhibitor of T-cell proliferation induced by CD3, suppressing IL2RA expression, IL2 secretion, and tyrosine kinase activity required for IL2 production and cellular proliferation.
  • CD101 inhibits phospholipase C-gamma-1/PLCG1 phosphorylation and subsequent CD3-induced changes in intracellular free calcium, while preventing nuclear translocation of NFAT.
  • The protein plays a role in suppressing T-cell proliferation through IL10 secretion by cutaneous dendritic cells.
  • Subcellular localization is primarily at the plasma membrane, consistent with its function as a cell surface receptor.
  • CD101 is expressed in lung, thymus, small intestine, cutaneous dendritic cells, activated T-cells, monocytes, granulocytes, and certain leukemic cells, including CD4+ CD56+ blastic tumor cells and Langerhans cells from LCH patients.
  • Key structural features include disulfide bonds, glycosylation, immunoglobulin domains, a signal peptide, and a transmembrane helix.
  • The protein may serve as a marker for CD4+ CD56+ leukemic tumor cells.

Experimental Guidance and Technical Tips

  • The immunogen (aa 21-410) corresponds to the extracellular region of human CD101, suggesting the antibody recognizes surface-exposed epitopes; for IF/ICC on live cells, permeabilization may not be required, but fixation and permeabilization conditions should be optimized for intracellular detection.
  • For flow cytometry (FC), consider using live cell staining protocols with appropriate Fc blocking and isotype controls; antibody titration is recommended to determine the optimal concentration for specific cell populations.
  • Validate the antibody in the relevant sample system, such as activated T-cells or CD101-expressing leukemic cell lines, to confirm specificity and performance.
  • Due to the conjugation, protect the antibody from light and avoid freeze-thaw cycles; brief centrifugation before use is advisable to remove aggregates.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio offers diagnostic manufacturers, laboratories, and research institutes streamlined access to specialized IVD raw materials like this anti-CD101 monoclonal antibody, ideal for T-cell immunology and oncology applications. Our comprehensive portfolio includes validated antibody pairs, optimized monoclonal and polyclonal antibodies, bulk ancillary reagents, and rare target raw-material sourcing, supporting your project from discovery to clinical development. We bridge the gap between concept and clinic with reliable, high-quality reagents and expert technical consultation.

View more faqs for this product

Product Datasheet

Rabbit anti-Human CD101/IGSF2 Monoclonal Antibody for IF/ICC, FC - Q93033


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!